A century-long history of many tragic events has played a pivotal role in shaping the present-day drug development structures and processes, none more so than those concerned with Pharmacovigilance—a valuable part of patient care throughout the world. Pharmacovigilance is central to drug safety. Pharmacovigilance analysis conducted during Phase I, Phase II, and Phase III clinical trials gives drug companies data on the drug’s safety profile. This data can be used for further R & D if necessary or submitted to regulatory authorities to allow new markets to be accessed. Both Pharmacovigilance practices done through medical professionals and consumers offer valuable insights into the safety profile of pharmaceutical medications. When a new adverse reaction is identified, the list of side effects on the label must be updated. At times, Pharmacovigilance data can lead to the removal of a drug from the market (drug recall) due to dangerous side effects. Thus, not only should healthcare administrators be aware of the Pharmacovigilance programme but the patients themselves should be made aware of this so that self-reporting increases, and the burden on the clinicians also reduces. For doctors to adequately care for their patients, drug safety must be monitored and reported from initial testing to everyday use. This is the world of Pharmacovigilance.
Ultimately, the goals of Pharmacovigilance are to bolster patientsafety concerning medicine use by providing a system to collect, assess, and distribute drug safety data. To help organizations and leaders select the best Pharmacovigilance Service Providers, Pharma Tech Outlook’s editorial board has shortlisted organizations that are distinctively prominent in the field of Pharmacovigilance, offering services coupled with innovative strategies. We present to you “Top 5 Pharmacovigilance Consulting/Services in UK - 2020.”
